255 related articles for article (PubMed ID: 29862299)
1. Epidermal Growth Factor Relieves Inflammatory Signals in
Choi SY; Lee YJ; Kim JM; Kang HJ; Cho SH; Chang SE
Biomed Res Int; 2018; 2018():9439182. PubMed ID: 29862299
[TBL] [Abstract][Full Text] [Related]
2. Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice.
Kim YJ; Choi MJ; Bak DH; Lee BC; Ko EJ; Ahn GR; Ahn SW; Kim MJ; Na J; Kim BJ
Sci Rep; 2018 Aug; 8(1):11895. PubMed ID: 30093649
[TBL] [Abstract][Full Text] [Related]
3. Substance P restores normal skin architecture and reduces epidermal infiltration of sensory nerve fiber in TNCB-induced atopic dermatitis-like lesions in NC/Nga mice.
Choi H; Kim DJ; Nam S; Lim S; Hwang JS; Park KS; Hong HS; Won Y; Shin MK; Chung E; Son Y
J Dermatol Sci; 2018 Mar; 89(3):248-257. PubMed ID: 29269174
[TBL] [Abstract][Full Text] [Related]
4. Roles of SEA-expressing Staphylococcus aureus, isolated from an atopic dermatitis patient, on expressions of human beta-defensin-2 and inflammatory cytokines in HaCaT cells.
Cho JW; Cho SY; Lee KS
Int J Mol Med; 2009 Mar; 23(3):331-5. PubMed ID: 19212650
[TBL] [Abstract][Full Text] [Related]
5. Effects of Josamycin on Scratching Behavior in NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions.
Matsui K; Nakamura M; Obana N
Biol Pharm Bull; 2021; 44(6):798-803. PubMed ID: 34078811
[TBL] [Abstract][Full Text] [Related]
6. Topical Application of Josamycin Inhibits Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice.
Matsui K; Tachioka K; Onodera K; Ikeda R
J Pharm Pharm Sci; 2017; 20():38-47. PubMed ID: 28459659
[TBL] [Abstract][Full Text] [Related]
7. Persistence of Staphylococcus aureus colonization on the skin of NC/Nga mice.
Hashimoto Y; Kaneda Y; Akashi T; Arai I; Nakaike S
J Dermatol Sci; 2004 Aug; 35(2):143-50. PubMed ID: 15265526
[TBL] [Abstract][Full Text] [Related]
8. Thymol attenuates the worsening of atopic dermatitis induced by Staphylococcus aureus membrane vesicles.
Kwon HI; Jeong NH; Jun SH; Son JH; Kim S; Jeon H; Kang SC; Kim SH; Lee JC
Int Immunopharmacol; 2018 Jun; 59():301-309. PubMed ID: 29679854
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of Rumex japonicus Houtt. on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Lee HS; Kim SK; Han JB; Choi HM; Park JH; Kim EC; Choi MS; An HJ; Um JY; Kim HM; Min BI
Br J Dermatol; 2006 Jul; 155(1):33-8. PubMed ID: 16792749
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus-derived membrane vesicles exacerbate skin inflammation in atopic dermatitis.
Jun SH; Lee JH; Kim SI; Choi CW; Park TI; Jung HR; Cho JW; Kim SH; Lee JC
Clin Exp Allergy; 2017 Jan; 47(1):85-96. PubMed ID: 27910159
[TBL] [Abstract][Full Text] [Related]
11. Topical treatments of Saussurea costus root and Thuja orientalis L. synergistically alleviate atopic dermatitis-like skin lesions by inhibiting protease-activated receptor-2 and NF-κB signaling in HaCaT cells and Nc/Nga mice.
Yang HJ; Kim MJ; Kang S; Moon NR; Kim DS; Lee NR; Kim KS; Park S
J Ethnopharmacol; 2017 Mar; 199():97-105. PubMed ID: 28159725
[TBL] [Abstract][Full Text] [Related]
12. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3.
Kisich KO; Carspecken CW; Fiéve S; Boguniewicz M; Leung DY
J Allergy Clin Immunol; 2008 Jul; 122(1):62-8. PubMed ID: 18538383
[TBL] [Abstract][Full Text] [Related]
13. Clarithromycin inhibits the development of dermatitis in NC/Nga mice.
Hashimoto Y; Kaneda Y; Takahashi N; Akashi S; Arai I; Nakaike S
Chemotherapy; 2003 Sep; 49(5):222-8. PubMed ID: 14504432
[TBL] [Abstract][Full Text] [Related]
14. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
15. The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies.
Hepburn L; Hijnen DJ; Sellman BR; Mustelin T; Sleeman MA; May RD; Strickland I
Br J Dermatol; 2017 Jul; 177(1):63-71. PubMed ID: 27779765
[TBL] [Abstract][Full Text] [Related]
16. Is/are pattern recognition receptor(s) for Staphylococcus aureus defective in atopic dermatitis?
Ong PY
Dermatology; 2006; 212(1):19-22. PubMed ID: 16319468
[TBL] [Abstract][Full Text] [Related]
17. IL-1β-Induced Protection of Keratinocytes against Staphylococcus aureus-Secreted Proteases Is Mediated by Human β-Defensin 2.
Wang B; McHugh BJ; Qureshi A; Campopiano DJ; Clarke DJ; Fitzgerald JR; Dorin JR; Weller R; Davidson DJ
J Invest Dermatol; 2017 Jan; 137(1):95-105. PubMed ID: 27702565
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway.
Vu AT; Baba T; Chen X; Le TA; Kinoshita H; Xie Y; Kamijo S; Hiramatsu K; Ikeda S; Ogawa H; Okumura K; Takai T
J Allergy Clin Immunol; 2010 Nov; 126(5):985-93, 993.e1-3. PubMed ID: 21050945
[TBL] [Abstract][Full Text] [Related]
19. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis.
Wichmann K; Uter W; Weiss J; Breuer K; Heratizadeh A; Mai U; Werfel T
Br J Dermatol; 2009 Aug; 161(2):300-5. PubMed ID: 19438853
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
